NIH/FDA dispute likely to delay research.
D026683:Advisory Committees; D004274:DNA, Recombinant / Q000627:therapeutic use*; D035082:Federal Government; D030342:Genetic Diseases, Inborn; D033161:Government Regulation; D006801:Humans; D009316:National Institutes of Health (U.S.); D012106:Research; D014481:United States; D014486:United States Food and Drug Administration
D004274:DNA, Recombinant